In the pathway analysis, inflammation-related pathways, including TNF, HIF-1, NF-κB, and VEGF signaling, are particularly enriched, indicating that the anti-inflammatory action of fucosterol could play a significant role in the treatment of NDD. The gene discussed is NFKB1; the disease is Neurodevelopmental delay.